biopharma-asset-valuation

Warn

Audited by Snyk on Aug 27, 2026

Risk Level: MEDIUM
Full Analysis

MEDIUM W011: Third-party content exposure detected (indirect prompt injection risk).

  • Third-party content exposure detected (medium risk: 0.30). 该技能在运行时会读取本地文件 references/real_deals_1394.json(描述为“用户上传的真实BD交易数据”)用于 Step 6 可比交易估值,属于外部作者可控的自由文本数据被直接摄入计算与写入报告。

Issues (1)

W011
MEDIUM

Third-party content exposure detected (indirect prompt injection risk).

Audit Metadata
Risk Level
MEDIUM
Analyzed
Aug 27, 2026, 01:23 AM
Issues
1